Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Researchers Push Forward Frontiers of Vaccine Science


 
James Crowe Jr., MD

Using sophisticated gene sequencing and computing techniques, researchers at Vanderbilt University Medical Center (VUMC) and the San Diego Supercomputer Center have achieved a first-of-its-kind glimpse into how the body's immune system gears up to fight off infection.

Their findings, published last month in the journal Nature, could aid development of "rational vaccine design," as well as improve detection, treatment and prevention of autoimmune diseases, infectious diseases, and cancer.

The study focused on antibody-producing white blood cells called B cells. These cells bear Y-shaped receptors that, like microscopic antenna, can detect an enormous range of germs and other foreign invaders. They do this by randomly selecting and joining together unique sequences of nucleotides known as receptor "clonotypes." In this way a small number of genes can lead to an incredible diversity of receptors, allowing the immune system to recognize almost any new pathogen.

Understanding exactly how this process works has been daunting. "Prior to the current era, people assumed it would be impossible to do such a project because the immune system is theoretically so large," said James Crowe Jr., MD, director of the Vanderbilt Vaccine Center and the paper's senior author. "This new paper shows it is possible to define a large portion," Crowe said, "because the size of each person's B cell receptor repertoire is unexpectedly small."

The researchers isolated white blood cells from three adults, and then cloned and sequenced up to 40 billion B cells to determine their clonotypes. They also sequenced the B-cell receptors from umbilical cord blood from three infants. This depth of sequencing had never been achieved before. What they found was a surprisingly high frequency of shared clonotypes. "The overlap in antibody sequences in between individuals was unexpectedly high," Crowe explained, "even showing some identical antibody sequences between adults and babies at the time of birth."

Understanding this commonality is key to identifying antibodies that can be targets for vaccines and treatments that work more universally across populations.

 
Share:

Related Articles:


Recent Articles

New Study Looks at Cost Impact of OTC Birth Control

A new study explores the impact on unintended pregnancies, consistent use of progestin-only OTC birth control pills at various price points.

Read More

Behavioral Health in a Time of Social Isolation

Last month, the Nashville Health Care Council brought together experts for a virtual panel discussion on behavioral health in the midst of social distancing orders.

Read More

COVID-19 & Mental Health

As the virus takes its toll, providers are finding new ways to reach patients and preparing for the mental health fallout ahead.

Read More

Self-Care on the Front Lines of Coronavirus

Physicians, nurses, respiratory therapists and the full complement of support staff at hospitals and clinics are battling coronavirus on the front lines. When caring for others, it's all too easy to forget to take care of yourself.

Read More

Sharing Best Practices in Behavioral Health

Nashville-based online video service provides evidence-based training to public and providers.

Read More

May is Mental Health Month

May is Mental Health Month with excellent resources from national organizations for both patients and providers.

Read More

Business Insights

Read More

Celebrating 15 Years of Incredible Leaders

Following are the 15 classes of Women to Watch. Some of these trailblazers have happily retired after a career of service. Others have moved to other positions and taken up new challenges since they were first recognized.

Read More

New Study Looks at Cost Impact of OTC Birth Control

A new study explores the impact on unintended pregnancies, consistent use of progestin-only OTC birth control pills at various price points.

Read More

AHA Releases Scientific Statement on CAD with Type 2 Diabetes

A new AHA scientific statement explores more aggressive clinical options for the patient-centered management of individuals with both type 2 diabetes and coronary artery disease.

Read More

Email Print
 
 

 

 


Tags:
rational vaccine design, San Diego Supercomputer Center, VUMC
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: